Allison Richards Selected Research

Melanoma (Melanoma, Malignant)

5/2019	BRAF Targeting Sensitizes Resistant Melanoma to Cytotoxic T Cells.
1/2018	Combination of Ipilimumab and Adoptive Cell Therapy with Tumor-Infiltrating Lymphocytes for Patients with Metastatic Melanoma.
4/2016	Phase I/II Study of Metastatic Melanoma Patients Treated with Nivolumab Who Had Progressed after Ipilimumab.
2/2016	Nivolumab in Resected and Unresectable Metastatic Melanoma: Characteristics of Immune-Related Adverse Events and Association with Outcomes.
2/2015	Safety, correlative markers, and clinical results of adjuvant nivolumab in combination with vaccine in resected high-risk metastatic melanoma.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Allison Richards Research Topics

Disease

5	Melanoma (Melanoma, Malignant) 05/2019 - 02/2015
4	Neoplasms (Cancer) 02/2021 - 02/2015
2	Exanthema (Rash) 02/2016 - 02/2015
1	Inflammation (Inflammations) 01/2019
1	Hypotension (Low Blood Pressure) 01/2019
1	Colitis 02/2016
1	Pruritus (Itching) 02/2015
1	Arthralgia (Joint Pain) 02/2015
1	Injection Site Reaction 02/2015
1	Nausea 02/2015
1	Fatigue 02/2015

Drug/Important Bio-Agent (IBA)

3	NivolumabIBA 04/2016 - 02/2015
2	IpilimumabIBA 01/2018 - 04/2016
1	ImmunosorbentsIBA 02/2021
1	EnzymesIBA 02/2021
1	InterferonsIBA 02/2021
1	Granzymes (Granzyme)IBA 05/2019
1	IGF Type 2 Receptor (Insulin-Like-Growth-Factor II Receptor)IBA 05/2019
1	Mitogen-Activated Protein Kinase Kinases (MEKs)IBA 05/2019
1	VemurafenibIBA 05/2019
1	BradykininIBA 01/2019
1	Blood Proteins (Serum Proteins)IBA 01/2019
1	Proteins (Proteins, Gene)FDA Link 01/2019
1	Complement System Proteins (Complement)IBA 01/2019
1	Interleukin-2 (IL2)IBA 01/2018
1	Pharmaceutical PreparationsIBA 04/2016
1	Lipase (Acid Lipase)FDA Link 02/2016
1	Amylases FDA Link 02/2016
1	montanide ISA 51IBA 02/2015
1	HLA-A*02:01 antigenIBA 02/2015
1	VaccinesIBA 02/2015
1	Protein Subunit VaccinesIBA 02/2015

Therapy/Procedure

2	Therapeutics 05/2019 - 02/2015
1	Cell- and Tissue-Based Therapy (Cell Therapy) 01/2018
1	Drug Therapy (Chemotherapy) 01/2018